Matthew R. Zibelman, MD, discusses differing opinions in muscle-invasive bladder cancer treatment he heard when moderating a Case-Based Roundtable event.

PJ DiPentino felt uneasy about his local oncologist’s plan. DiPentino’s bladder cancer had returned in a lymph node, and the ...

The withdrawal of the FDA accelerated approval for locally advanced or metastatic urothelial carcinoma, a type of bladder ...

Prostate cancer is one of the most common forms of cancer in men – affecting over 55,000 a year in the UK, with 150 new cases ...

Mary Bird Perkins Cancer Center in Metairie will be led by a team of three physicians: Dr. Scott Delacroix, Dr. Jessie Gills, ...

If you are not acknowledging your powerless feelings about stressful events in your life, the appearance of a gorilla in your ...

On Tuesdays in October, which is National Breast Cancer Awareness Month, local survivors are sharing their breast ...

Gilead has made the decision to withdraw the accelerated approval of Trodelvy (sacituzumab govitecan) for advanced urothelial cancer in the United States.

Updated results from the CheckMate 274 trial support the use of adjuvant nivolumab as standard care for high-risk muscle-invasive urothelial carcinoma, according to researchers.

The optimal duration of perioperative antibiotic prophylaxis in patients undergoing cystectomy is within 24 hours, research confirms.

Terry Bradshaw has been a mainstay on Fox NFL Sunday for nearly 30 years, but the NFL legend has dealt with a number of ...

The FISH testing market is booming, driven by its expanding role in diagnosing genetic disorders, personalizing cancer ...